High Lipoprotein(a) Levels' Hit on Heart Health Doesn't Discriminate Atherogenic particle appeared to be a risk factor regardless of age, sex, race, diabetes status Apr 15, 2024
No Link Between GLP-1 Drugs and Suicide, Says European Regulator EMA announcement comes a few months after FDA's preliminary evaluation Apr 12, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm News and commentary from the endocrinology world Apr 09, 2024
Chelation Flops for Cardio Health After Heart Attack TACT2 trial fails to confirm benefits in subgroup that gained the most in initial trial Apr 08, 2024
Wegovy Helps HFpEF Patients With Diabetes Mellitus Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
Specialty Care Access Not Equal Among Teens With Diabetes Claims for specialists significantly lower for youth with type 2 versus type 1 diabetes Apr 05, 2024
Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizations Secondary outcomes also showed no significant differences Apr 03, 2024
Diabetes Drug Shows Benefit in Parkinson's Disease Phase II study of GLP-1 drug lixisenatide meets primary endpoint Apr 03, 2024
Weight-Loss Drug Zepbound Faces Supply Issues Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Risk Overall incidence is still low, however Apr 01, 2024
When Medicalization Goes Too Far The boundaries between health and disease often get a little blurry Mar 31, 2024
Here's What OTC Continuous Glucose Monitors Can Do for Our Patients FDA's approval may be a step toward greater access Mar 30, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
Out-of-Pocket Insulin Caps Boost Savings -- But Not Insulin Use Proposed national $35 insulin cap would help some patients, researchers say Mar 25, 2024
Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
Is SGLT2 Inhibitor-Associated Ketoacidosis Treated With Enough Insulin? Study suggests these patients receive significantly lower doses vs those with T1D ketoacidosis Mar 18, 2024
Slowing of Peripheral Artery Disease: Another Liraglutide Benefit? GLP-1 receptor agonist significantly slowed progression over 6 months Mar 13, 2024
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes News and commentary from the endocrinology world Mar 12, 2024
Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Cardiometabolic Disorders Tend to Accompany a 'Lazy Eye' Persistent amblyopia associated with myocardial infarction and death Mar 08, 2024
One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? Even following this rule, increased residual gastric content still prevalent Mar 07, 2024
FDA Clears First OTC Continuous Glucose Monitor Dexcom's Stelo system available without a prescription by the summer Mar 06, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
FDA Says Eating Yogurt May Reduce Diabetes Risk Products will be allowed to carry claims as long as they don't mislead consumers Mar 04, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
FDA: Don't Use Smartwatches, Smart Rings for Blood Glucose Measurements Noninvasive devices that don't pierce the skin can give inaccurate measurements Feb 22, 2024
T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals News and commentary from the endocrinology world Feb 20, 2024
States Target Health Insurers' Red Tape Around Prior Authorization Pending bills in multiple states include policies backed by the AMA Feb 19, 2024
SGLT2 Inhibitors Tied to Better NAFLD Outcomes vs Other Antidiabetic Agents Class of drug associated with highest odds of NAFLD regression for patients with type 2 diabetes Feb 14, 2024
Denosumab Protective Against Diabetes? Study found lower diabetes incidence with osteoporosis drug for patients who stayed on treatment Feb 13, 2024
Rapid Weight Loss a Diabetic Retinopathy Risk? While research is conflicting, GLP-1 therapies might cause transient worsening of retinal disease Feb 12, 2024
Can a Common Diabetes Drug Turn Patients' Urine Into Alcohol? Case study highlights importance of proper urine sample storage Feb 07, 2024
More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Durable Weight Loss Follows Just a Few Injections of Novel Drug Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
Health Effects of Diabetes Remission; High-Deductible Plans for Cancer Patients Also in TTHealthWatch: USPSTF weighs in on screening for language disorders or delays in kids Feb 03, 2024 podcast
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
One Class of Antidiabetic Linked With Lower Kidney Stone Risk Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors Jan 29, 2024